| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0016 |
1 |
| mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
-0.0015 |
1 |
| mRNA |
WZ8040 |
CTRPv2 |
pan-cancer |
AAC |
-0.0017 |
1 |
| mRNA |
Elesclomol |
GDSC1000 |
pan-cancer |
AAC |
0.0011 |
1 |
| mRNA |
Bicalutamide |
GDSC1000 |
pan-cancer |
AAC |
-0.0011 |
1 |
| mRNA |
WH-4-023 |
GDSC1000 |
pan-cancer |
AAC |
-0.0017 |
1 |
| mRNA |
BRD-K99584050 |
CTRPv2 |
pan-cancer |
AAC |
0.0019 |
1 |
| mRNA |
Doxorubicin |
FIMM |
pan-cancer |
AAC |
-0.0037 |
1 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.001 |
1 |
| mRNA |
BRD-K29086754 |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
1 |